Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Casa Sollievo della Sofferenza is a world-renowned research hospital and IRCCS (Scientific Institute for Research, Hospitalization and Healthcare) located in San Giovanni Rotondo, Italy. Founded by Saint Pio of Pietrelcina in 1956 and owned by the Holy See, it serves as a major healthcare hub and a center for advanced biomedical research. The institute is particularly distinguished in the fields of medical genetics, oncology, and regenerative medicine, operating the specialized ISBReMIT facility for stem cell biology. It leads several high-profile clinical trials, most notably involving human neural stem cell transplantation for neurodegenerative diseases like ALS and Multiple Sclerosis. By integrating high-tech diagnostic services with cutting-edge translational research, the organization remains a key player in the European healthcare and biotech landscape.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Casa Sollievo della Sofferenza.